Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Biochem Pharmacol. 2010 Jun 10;80(7):1063–1074. doi: 10.1016/j.bcp.2010.06.002

Fig. 5.

Fig. 5

Relative quantitation of urinary metabolites from different groups of metabolic pathways in mouse urine following the treatment of IF and CP. Except for unchanged IF and CP, there were significant differences in these metabolites with similar chemical structures from IF and CP. NS, not significant. Note that the β-elimination of acrolein (IF>CP; P<0.05) and glucuronidation (CP>IF; P<0.01) pathways were very minor compared to other pathways, but nevertheless showed statistically significant differences.